Pilot study of OXP001 and Brufen in Healthy Subjects(OXP001-002)

• Research type

  Research Study

• Full title

  A Randomised, Open Label, Evaluator Blinded, Multiple Dose, Parallel Arm, Phase I Pilot Study of OXP001 400 mg Tablets and Brufen 400 mg Tablets in Normal, Healthy, Adult, Human Subjects Under Fasting Conditions to Assess The Incidence of Upper Gastrointestinal Irritation

• IRAS ID

  146818

• Contact name

  Stuart Mair

• Contact email

  stuart.mair@quotientclinical.com

• Sponsor organisation

  Oxford PharmaScience

• Eudract number

  2013-005123-16

• ISRCTN Number

  to be registered

• REC name

  Wales REC 2

• REC reference

  14/WA/0020

• Date of REC Opinion

  5 Feb 2014

• REC opinion

  Further Information Favourable Opinion